- Takeda is considering a new bid for Adderall drugmaker Shire, raising the share price to 47 British pounds (about $US66) per share up from 46.50 per share (about $US65), Bloomberg reported Friday.
- Shire has already turned down three offers from the Japanese pharmaceutical company, the last of which was a 50% premium on Shire’s stock price on March 27
- Interest in Shire almost turned into a bidding war between Takeda and Allergan before Allergan pulled out just four hours after initially expressing interest in a potential deal.
Business Insider Emails & Alerts
Site highlights each day to your inbox.